Alternative application of an iTrack microcatheter and canaloplasty: case report and literature review

References

• Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105(3):493–510. doi: 10.1016/j.mcna.2021.01.004
   PubMed Web of Science ®Google Scholar
• Khaimi M. Canaloplasty using iTrack 250 microcatheter with suture tensioning on Schlemm′s canal. Middle East Afr J Ophthalmol. 2009;16(3):127. doi: 10.4103/0974-9233.56224
   PubMedGoogle Scholar
• Byszewska A, Konopińska J, Kicińska AK, et al. Canaloplasty in the treatment of primary open-angle glaucoma: patient selection and perspectives. Clin Ophthalmol. 2019; Dec 31;13:2617–2629. doi: 10.2147/OPTH.S155057
   PubMed Web of Science ®Google Scholar
• Kicińska AK, Danielewska ME, Rękas M. Safety and efficacy of three variants of canaloplasty with phacoemulsification to treat open-angle glaucoma and cataract: 12-month follow-up. J Clin Med. 2022;11(21):6501. doi: 10.3390/jcm11216501
   PubMed Web of Science ®Google Scholar
• Carassa RG, Bettin P, Fiori M, et al. Viscocanalostomy: a pilot study. Acta Ophthalmol Scand Suppl. 1998;227:51–52. doi: 10.1111/j.1600-0420.1998.tb00886.x
   Google Scholar
• Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25(3):316–322. doi: 10.1016/S0886-3350(99)80078-9
   PubMed Web of Science ®Google Scholar
• Cameron B, Field M, Ball S, et al. Circumferential viscodilation of Schlemm’s canal with a flexible microcannula during non-penetrating glaucoma surgery. Digit J Ophthalmol. 2006;12(1). https://www.djo.harvard.edu/site.php?url=/physicians/oa/929.
   Google Scholar
• Ranta VP, Urtti A. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling. Adv Drug Deliv Rev. 2006;58(11):1164–1181. doi: 10.1016/j.addr.2006.07.025
   PubMed Web of Science ®Google Scholar
• Kang-Mieler JJ, Osswald CR, Mieler WF. Advances in ocular drug delivery: emphasis on the posterior segment. Expert Opin Drug Deliv. 2014;11(10):1647–1660. doi: 10.1517/17425247.2014.935338
   PubMed Web of Science ®Google Scholar
• Kayla JJK, Wenqiang MR, William L. Advances in ocular drug delivery systems. Eye. 2020;34(8):1371–1379. doi: 10.1038/s41433-020-0809-0
   PubMed Web of Science ®Google Scholar
• Rizzo S, Ebert FG, Di Bartolo E, et al. Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates. Retina. 2012;32(4):776–784. doi: 10.1097/IAE.0b013e3182278b0e
   PubMed Web of Science ®Google Scholar
• Tetz M, Rizzo S, Augustin AJ. Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results. Ophthalmologica. 2012;227(4):183–189. doi: 10.1159/000336045
   PubMed Web of Science ®Google Scholar
• Olsen TW, Feng X, Wabner K, et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol. 2006;142(5):777–787. doi: 10.1016/j.ajo.2006.05.045
   PubMed Web of Science ®Google Scholar
• Chen M, Li X, Liu J, et al. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model. J Control Release. 2015;10(203):109–117. doi: 10.1016/j.jconrel.2015.02.021
   Google Scholar
• Robinson MR, Lee SS, Kim H, et al. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res. 2006;82(3):479–487. doi: 10.1016/j.exer.2005.08.007
   PubMed Web of Science ®Google Scholar
• Peden MC, Min J, Meyers C, et al. Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter. PLoS One. 2011;6(2):17140. doi: 10.1371/journal.pone.0017140
   PubMed Web of Science ®Google Scholar
• de Smet MD, Wyse S, Vezina M, et al. Repeated ab-externo catheterization of the sub-retinal space using a microcatheter for targeted delivery of a cell therapy product in a pig model. Invest Ophthalmol Vis Sci. 2012;53(14):5844.
   Google Scholar
• Kang SJ, Patel SR, Berezovsky DE, et al. Suprachoroidal injection of microspheres with microcatheter in a rabbit model of uveal melanoma. Invest Ophthalmol Vis Sci. 2011;52(14):1459.
   Google Scholar
• Ho AC, Chang TS, Samuel M, et al. Experience with a subretinal cell-based therapy in patients with geographic atrophy secondary to age-related macular degeneration. Am J Ophthalmol. 2017;179:67–80. doi: 10.1016/j.ajo.2017.04.006
   PubMed Web of Science ®Google Scholar
• Yiu G, Chung SH, Mollhoff IN, et al. Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates. Mol Ther - Methods Clin Dev. 2020;16:179–191. doi: 10.1016/j.omtm.2020.01.002
   PubMed Web of Science ®Google Scholar
• Olsen TW, Feng X, Wabner K, et al. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Investig Ophthalmol Vis Sci. 2011;52(7):4749–4756. doi: 10.1167/iovs.10-6291
   PubMed Web of Science ®Google Scholar
• Mori K, Gehlbach P, Yamamoto S, et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Investig Ophthalmol Vis Sci. 2002;43(6):1994–2000.
   PubMed Web of Science ®Google Scholar
• Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Investig Ophthalmol Vis Sci. 1989;30(2):233–238.
   PubMed Web of Science ®Google Scholar
• Krohn J, Bertelsen T. Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the pig eye. Acta Ophthalmol Scand. 1997;75(1):28–31. doi: 10.1111/j.1600-0420.1997.tb00244.x
   PubMedGoogle Scholar
• Höh H, Grisanti S, Rau M, et al. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd. 2014;231(4):377–381. doi: 10.1055/s-0034-1368214
   PubMed Web of Science ®Google Scholar
• Wellik SR, Dale EA. A review of the iStent ® trabecular micro-bypass stent: safety and efficacy. Clin Ophthalmol. 2015;15(9):677–684. doi: 10.2147/OPTH.S57217
   Google Scholar
• Yeh S, Khurana RN, Shah M, et al. Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial. Ophthalmology. 2020;127(7):948–955. doi: 10.1016/j.ophtha.2020.01.006
   PubMed Web of Science ®Google Scholar
• Maepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm ’ s canal in monkeys. Exp Eye Res. 1992;54:879–883. doi: 10.1016/0014-4835(92)90151-h
   PubMed Web of Science ®Google Scholar
• Overby DR, Stamer WD, Johnson M. The changing paradigm of outflow resistance generation: towards synergistic models of the JCT and inner wall edothelium. Exp Eye Res. 2009;88(4):656–670. doi: 10.1016/j.exer.2008.11.033
   PubMed Web of Science ®Google Scholar
• Liu X, Rasmussen CA, Gabelt BAT, et al. Gene therapy targeting glaucoma: where are we? Surv Ophthalmol. 2009;54(4):472–486. doi: 10.1016/j.survophthal.2009.04.003
   PubMed Web of Science ®Google Scholar
• Rao PV, Deng P, Sasaki Y, et al. Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility *. Exp Eye Res. 2005;80:197–206. doi: 10.1016/j.exer.2004.08.029
   PubMed Web of Science ®Google Scholar
• Honjo M, Tanihara H, Inatani M, et al. Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Investig Ophthalmol Vis Sci. 2001;42(1):137–144.
   PubMed Web of Science ®Google Scholar
• Erickson-Lamy K, Schroeder A, Epstein DL. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Investig Ophthalmol Vis Sci. 1992;33(9):2631–2640.
   PubMed Web of Science ®Google Scholar
• Peterson JA, Tian B, Geiger B, et al. Effect of latrunculin-B on outflow facility in monkeys. Exp Eye Res. 2000;70(3):307–313. doi: 10.1006/exer.1999.0797
   PubMed Web of Science ®Google Scholar
• Rao PV, Deng P, Kumar J, et al. Modulation of aqueous humor outflow facility by the Rho kinase – specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029–1037.
   PubMed Web of Science ®Google Scholar
• Rao PV, Deng P, Maddala R, et al. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis. 2005;11(March):288–297.
   PubMedGoogle Scholar
• Tian B, Kaufman PL. Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin a on outflow facility in monkeys *. Exp Eye Res. 2005;80(2):215–225. doi: 10.1016/j.exer.2004.09.002
   PubMed Web of Science ®Google Scholar
• Aktories K, Mohr C, Koch G. Clostridium botulinum C3 ADP-ribosyltransferase. Curr Top Microbiol. 1992;175:115–131.
   PubMed Web of Science ®Google Scholar
• Liu X, Hu Y, Filla MS, et al. The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis. 2005;11:1112–1121. http://europepmc.org/abstract/MED/16379023
   PubMed Web of Science ®Google Scholar
• Grosheva I, Vittitow JL, Goichberg P, et al. Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells. Exp Eye Res. 2006;82(6):945–958. doi: 10.1016/j.exer.2006.01.006
   PubMed Web of Science ®Google Scholar
• Gabelt BT, Hu Y, Vittitow JL, et al. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Experimental Eye Research. 2006;82(6):935–944. doi: 10.1016/j.exer.2005.12.002
   PubMed Web of Science ®Google Scholar
• Swaminathan SS, Oh DJ, Kang MH, et al. Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow. Investig Ophthalmol Vis Sci. 2013;54(3):2035–2047. doi: 10.1167/iovs.12-10950
   PubMed Web of Science ®Google Scholar
• Haddadin RI, Oh DJ, Kang MH, et al. Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. Investig Ophthalmol Vis Sci. 2012;53(10):6708–6717. doi: 10.1167/iovs.11-9013
   PubMed Web of Science ®Google Scholar
• Oh DJ, Kang MH, Ooi YH, et al. Overexpression of SPARC in human trabecular meshwork increases intraocular pressure and alters extracellular matrix. Investig Ophthalmol Vis Sci. 2013;54(5):3309–3319. doi: 10.1167/iovs.12-11362
   PubMed Web of Science ®Google Scholar
• Kee C, Sohn S, Hwang J. Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo and. Invest Ophthalmol Vis Sci. 2001;42(12):2856–2860.
   PubMed Web of Science ®Google Scholar
• Hudde T, Apitz J, Bordes-Alonso R, et al. Gene transfer to trabecular meshwork endothelium via direct injection into the Schlemm canal and in vivo toxicity study. Curr Eye Res. 2005;30(12):1051–1059. doi: 10.1080/02713680500323350
   PubMed Web of Science ®Google Scholar
• Borrás T, Gabelt BT, Klintworth GK, et al. Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J Gene Med. 2001;3(5):437–449. doi: 10.1002/jgm.210
   PubMed Web of Science ®Google Scholar
• Tian B, Kaufman PL. A potential application of canaloplasty in glaucoma gene therapy. Transl Vis Sci Technol. 2013;2(1):2. doi: 10.1167/tvst.2.1.2
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Pienaar A, Olivier J, et al. Clinical evaluation of the aqueous outflow system in primary open-angle glaucoma for canaloplasty. Investig Ophthalmol Vis Sci. 2010;51(3):1498–1504. doi: 10.1167/iovs.09-4327
   PubMed Web of Science ®Google Scholar
• Daniel Stamer W, Chan D.W.-H., Ross Ethier, C. Targeted gene transfer to Schlemm’s canal by retroperfusion. Experimental Eye Research. 2008;84(5):843–849. doi: 10.1016/j.exer.2007.01.001
   Web of Science ®Google Scholar
• Tamm ER, Carassa RG, Albert DM, et al. Viscocanalostomy in rhesus monkeys. Arch Ophthalmol. 2004;122(12):1826–1838. doi: 10.1001/archopht.122.12.1826
   PubMedGoogle Scholar
• Ethier RC, Coloma FM, de Kater AW, et al. Retroperfusion studies of the aqueous outflow system part 2: studies in human eyes. Investig Ophthalmol Vis Sci. 1995;36(12):2466–2475.
   PubMed Web of Science ®Google Scholar
• Aktas Z, Tian B, McDonald J, et al. Application of canaloplasty in glaucoma gene therapy. J Ocul Pharmacol Ther. 2014;30(2–3):277–282. doi: 10.1089/jop.2013.0203
   PubMed Web of Science ®Google Scholar
• Körber N, Kanaloplastik A, Fallseriestudie G. Ab interno canaloplasty for the treatment of glaucoma: a case series study. Spektrum Augenheilkd. 2018;32(6):223–227. doi: 10.1007/s00717-018-0416-7
   PubMed Web of Science ®Google Scholar
• Khaimi MA. Canaloplasty: a minimally invasive and maximally effective glaucoma treatment. Funk J, ed. J Ophthalmol. 2015;2015:485065. doi: 10.1155/2015/485065
   PubMed Web of Science ®Google Scholar
• Rękas M, Konopińska J, Byszewska A, et al. Mini-canaloplasty as a modified technique for the surgical treatment of open-angle glaucoma. Sci Rep. 2020;10(1):1–7. doi: 10.1038/s41598-020-69261-y
   PubMed Web of Science ®Google Scholar
• Xue K, Groppe M, Salvetti AP, et al. Technique of retinal gene therapy: delivery of viral vector into the subretinal space. Eye. 2017;31(9):1308–1316. doi: 10.1038/eye.2017.158
   PubMed Web of Science ®Google Scholar
• Goldberg JL, Beykin G, Satterfield KR, et al. Phase I NT-501 ciliary neurotrophic factor implant trial for primary open angle glaucoma: safety, neuroprotection and neuroenhancement. Ophthalmol Sci. 2023;3(3):100298. doi: 10.1016/j.xops.2023.100298
   PubMedGoogle Scholar
• Borrás T. The pathway from genes to gene therapy in glaucoma: a review of possibilities for using genes as glaucoma drugs. Asia-Pacific J Ophthalmol. 2017;6(1):80–93. doi: 10.22608/APO.2016126
   PubMedGoogle Scholar